FORM 3
        	UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
	OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5	
                      	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	                      	

1. Name and Address of Reporting Person *

LEVITAN DAN	2. Date of Event Requiring Statement (MM/DD/YYYY)
7/17/2014 
	3. Issuer Name and Ticker or Trading Symbol

TRUPANION INC. [TRUP]	
(Last)        (First)        (Middle)

C/O TRUPANION, INC., 907 NW BALLARD WAY	4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                            ___ X ___ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)	
(Street)

SEATTLE, WA 98107       

(City)              (State)              (Zip)	5. If Amendment, Date Original Filed (MM/DD/YYYY)

	6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person	

Table I - Non-Derivative Securities Beneficially Owned	
1.Title of Security
(Instr. 4)	2. Amount of Securities Beneficially Owned
(Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)	4. Nature of Indirect Beneficial Ownership
(Instr. 5)	
Common Stock  	126231  	I  	By Maveron Equity Partners III, L.P.   (1)	
Common Stock  	5356  	I  	By Maveron III Entrepreneurs? Fund L.P.   (2)	
Common Stock  	17307  	I  	By MEP Associates III, L.P.   (3)	

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)	
1. Title of Derivate Security
(Instr. 4)	2. Date Exercisable and Expiration Date
(MM/DD/YYYY)	3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)	6. Nature of Indirect Beneficial Ownership
(Instr. 5)	
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares				
Series A Convertible Preferred Stock  	  (4)	  (4)	Common Stock  	3673730  	  (4)	I  	By Maveron Equity Partners III, L.P.   (1)	
Series A Convertible Preferred Stock  	  (4)	  (4)	Common Stock  	155880  	  (4)	I  	By Maveron III Entrepreneurs? Fund L.P.   (2)	
Series A Convertible Preferred Stock  	  (4)	  (4)	Common Stock  	503720  	  (4)	I  	By MEP Associates III, L.P.   (3)	
Series B Convertible Preferred Stock  	  (5)	  (5)	Common Stock  	1210920  	  (5)	I  	By Maveron Equity Partners III, L.P.   (1)	
Series B Convertible Preferred Stock  	  (5)	  (5)	Common Stock  	51364  	  (5)	I  	By Maveron III Entrepreneurs? Fund L.P.   (2)	
Series B Convertible Preferred Stock  	  (5)	  (5)	Common Stock  	166032  	  (5)	I  	By MEP Associates III, L.P.   (3)	
Series C Convertible Preferred Stock  	  (6)	  (6)	Common Stock  	545165  	  (6)	I  	By Maveron Equity Partners III, L.P.   (1)	
Series C Convertible Preferred Stock  	  (6)	  (6)	Common Stock  	23131  	  (6)	I  	By Maveron III Entrepreneurs? Fund L.P.   (2)	
Series C Convertible Preferred Stock  	  (6)	  (6)	Common Stock  	74750  	  (6)	I  	By MEP Associates III, L.P.   (3)	

Explanation of Responses:	
(  1) 	The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron General Partner III LLC ("Maveron LLC"), which is the general partner of Maveron Equity Partners III, L.P. ("Maveron Equity"), and may be deemed to share voting and investment power over the securities held by Maveron Equity. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.	
(  2) 	The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron LLC, which is the General Partner of Maveron III Entrepreneurs' Fund L.P. ("Maveron Entrepreneurs"), and may be deemed to share voting and investment power over the securities held by Maveron Entrepreneurs. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.	
(  3) 	The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron LLC, which is the General Partner of MEP Associates III, L.P. ("MEP"), and may be deemed to share voting and investment power over the securities held by MEP. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.	
(  4) 	Each share of the issuer's Series A Convertible Preferred Stock will be converted into 1 share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering ("IPO") and has no expiration date.	
(  5) 	Each share of the issuer's Series B Convertible Preferred Stock will be converted into 1 share of the issuer's Common Stock immediately upon the closing of the issuer's IPO and has no expiration date.	
(  6) 	Each share of the issuer's Series C Convertible Preferred Stock will be converted into 1 share of the issuer's Common Stock immediately upon the closing of the issuer's IPO and has no expiration date.	

Reporting Owners	
Reporting Owner Name / Address	Relationships	
	Director	10% Owner	Officer	Other	
LEVITAN DAN
C/O TRUPANION, INC.
907 NW BALLARD WAY
SEATTLE, WA 98107	X	X			

Signatures		
/s/ Charlotte Sim-Warner as attorney-in-fact for Dan Levitan		7/17/2014	
** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.	
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).	
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).	
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.	
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.	

LIMITED POWER OF ATTORNEY
The undersigned hereby constitutes and appoints the responsible officers, attorney and paralegal of Trupanion, Inc. (the "Company"), including Darryl Rawlings, Asher Bearman, Charlotte Sim-Warner, as long as they are providing services to the Company, and the responsible attorneys and paralegals of Fenwick & West LLP ("Fenwick"), or either of them, the undersigned's true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of the Company, Forms 3, 4s and 5s in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the rules and regulations thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute any such Forms 3, 4s and 5s and timely file such forms with the Securities and Exchange Commission and any stock exchange or similar authority, if required; and
(3) take any other action of any type whatsoever in connection with the foregoing that, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform each and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution and revocation, hereby ratifying and confirming all that each such attorney-in-fact, or each such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that each of the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company or Fenwick assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act.
The undersigned agrees that each such attorney-in-fact may rely entirely on information furnished orally or in writing by the undersigned to each such attorney-in-fact. The undersigned also agrees to indemnify and hold harmless the Company and Fenwick and each such attorney-in-fact against any losses, claims, damages or liabilities (or actions in these respects) that arise out of or are based on any untrue statement or omission of necessary facts in the information provided by the undersigned to such attorney-in-fact for purposes of executing, acknowledging, delivering and filing Forms 3, 4s or 5s (including amendments thereto) and agrees to reimburse the Company and Fenwick and each such attorney-in-fact for any legal or other expenses reasonably incurred in connection with investigating or defending against any such loss, claim, damage, liability or action.
This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4s and 5s with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 9th day of July, 2014.

/s/     DAN LEVITAN
Name:  Dan Levitan